Search Results

angiotensin II-induced calcium signaling in striatal neurons Rafael Rivas-Santisteban , Ana Muñoz , Jaume Lillo , Iu Raïch , Ana Rodríguez-Pérez , Gemma Navarro , José Labandeira-García , Rafael Franco Endomembrane

the Formation of a Cross-Functional Scientific and Drug Discovery Advisory Board Sosei Heptares and Lilly

First R&D Milestone Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio Lilly

After 7 years at WL/PD and 26 years at Eli Lilly & Co., he retired at the end of 2014 and since then has been writing papers on his final major project at Lilly, a dopamine D1 PAM series that has advanced In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

Hit-ID Chemistry Lead - Septerna Junior associate position and a PhD/post-doc level position - Eli Lilly

of new drugs targeting specific receptors for various diseases, with Arthur sharing insights on Eli Lilly's